In a comparison of KRAS ON with KRAS OFF paired samples in a recent study27, we found that oncogenic KRAS mutations upregulated ZDHHC20 protein expression in pancreatic cancer (Fig. S4A). The gene discussed is ZDHHC20; the disease is pancreatic neoplasm.